Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
- PMID: 27094482
- PMCID: PMC4906150
- DOI: 10.1016/j.parkreldis.2016.04.009
Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
Abstract
Introduction: Parkinson's disease dementia (PDD) is associated with poorer quality of life (QoL). Prior to the onset of PDD, many patients experience progressive cognitive impairment. There is a paucity of longitudinal studies investigating the effects of cognitive decline on QoL. This study aimed to determine the longitudinal impact of cognitive change on QoL in an incident PD cohort.
Methods: Recently diagnosed patients with PD (n = 212) completed a schedule of neuropsychological assessments and QoL measures; these were repeated after 18 (n = 190) and 36 months (n = 158). Mild cognitive impairment (PD-MCI) was classified with reference to the Movement Disorder Society criteria. Principal component analysis was used to reduce 10 neuropsychological tests to three cognitive factors: attention, memory/executive function, and global cognition.
Results: Baseline PD-MCI was a significant contributor to QoL (β = 0.2, p < 0.01). For those subjects (9%) who developed dementia, cognitive function had a much greater impact on QoL (β = 10.3, p < 0.05). Multivariate modelling showed attentional deficits had the strongest predictive power (β = -2.3, p < 0.01); brief global tests only modestly predicted decline in QoL (β = -0.4, p < 0.01).
Conclusions: PD-MCI was associated with poorer QoL over three years follow up. Cognitive impairment had a greater impact on QoL in individuals who developed dementia over follow-up. Impaired attention was a significant determinant of QoL in PD. Interventions which improve concentration and attention in those with PD could potentially improve QoL.
Keywords: Attention; Dementia; Mild cognitive impairment; Parkinson's disease; Quality of life.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
References
-
- Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 2008;23:837–844. - PubMed
-
- Leroi I., McDonald K., Pantula H., Harbishettar V. Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. J. Geriatr. Psychiatry Neurol. 2012;25:208–214. - PubMed
-
- Visser M., Verbaan D., van Rooden S., Marinus J., van Hilten J., Stiggelbout A. A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health. 2009;12:392–396. - PubMed
-
- Antonini A., Barone P., Marconi R., Morgante L., Zappulla S., Pontieri F., Ramat S., Ceravolo M., Meco G., Cicarelli G., Pederzoli M., Manfredi M., Ceravolo R., Mucchiut M., Volpe G., Abbruzzese G., Bottacchi E., Bartolomei L., Ciacci G., Cannas A., Randisi M., Petrone A., Baratti M., Toni V., Cossu G., Dotto P., Bentivoglio A., Abrignani M., Scala R., Pennisi F., Quatrale R., Gaglio R., Nicoletti A., Perini M., Avarello T., Pisani A., Scaglioni A., Martinelli P., Iemolo F., Ferigo L., Simone P., Soliveri P., Troianiello B., Consoli D., Mauro A., Lopiano L., Nastasi G., Colosimo C. The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J. Neurol. 2012;259:2621–2631. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
